+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies



International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies



Arthritis and Rheumatism 52(9): 2607-2615




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 049380538

Download citation: RISBibTeXText

PMID: 16142757

DOI: 10.1002/art.21291


Related references

International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology 43(1): 49-54, 2003

Study of idiopathic inflammatory myopathies with special reference to borderland between idiopathic inflammatory myopathies and muscular dystrophies. Neurology India 56(3): 356-362, 2008

Modern Therapies for Idiopathic Inflammatory Myopathies (IIMs): Role of Biologics. Clinical Reviews in Allergy and Immunology 52(1): 81-87, 2017

Clinical trials roundup in idiopathic inflammatory myopathies. Current Opinion in Rheumatology 23(6): 605-611, 2011

Recent clinical trials in idiopathic inflammatory myopathies. Current Opinion in Rheumatology 29(6): 652-659, 2017

Targeted immunotherapy trials for idiopathic inflammatory myopathies. Journal of Neurology 260(2): 368-385, 2013

Recent developments in classification criteria and diagnosis guidelines for idiopathic inflammatory myopathies. Current Opinion in Rheumatology 30(6): 606-613, 2018

Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus. Journal of Rheumatology 46(2): 190-197, 2019

A national registry for juvenile dermatomyositis and other paediatric idiopathic inflammatory myopathies: 10 years' experience; the Juvenile Dermatomyositis National (UK and Ireland) Cohort Biomarker Study and Repository for Idiopathic Inflammatory Myopathies. Rheumatology 50(1): 137-145, 2011

Perceptions of Patients, Caregivers, and Healthcare Providers of Idiopathic Inflammatory Myopathies: An International OMERACT Study. Journal of Rheumatology 46(1): 106-111, 2019

International consensus recommendations. Summary statement and additional suggested guidelines. European Consensus Conference, November 1991. American College of Chest Physicians consensus statement of 1995. International Consensus Statement, 1997. Medical Clinics of North America 82(3): 613-633, 1998

193rd ENMC International workshop Pathology diagnosis of idiopathic inflammatory myopathies 30 November - 2 December 2012, Naarden, The Netherlands. Neuromuscular Disorders 23(11): 945-951, 2013

205th ENMC International Workshop: Pathology diagnosis of idiopathic inflammatory myopathies part II 28-30 March 2014, Naarden, The Netherlands. Neuromuscular Disorders 25(3): 268-272, 2015

International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease. Blood 132(20): 2115-2124, 2018

Differentiating idiopathic inflammatory myopathies from metabolic myopathies. Rheumatic Diseases Clinics of North America 28(4): 759-778, 2002